/Bristol-Myers%20Squibb%20Co_%20logo%20on%20building-by%20tatu%20Campelo%20via%20iStock.jpg)
New Jersey-based Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical giant focused on discovering, developing and delivering innovative medicines for serious diseases, with core areas including oncology, immunology, cardiovascular conditions and blood disorders. Bristol-Myers Squibb commands a powerful presence in oncology, led by blockbuster immuno-oncology therapies including Opdivo, Opdivo Qvantig, and Yervoy, among others.
With a market capitalization of around $100.3 billion, Bristol-Myers comfortably sits in the “large-cap” tier, a class that generally includes companies valued at $10 billion or more. Through a strong pipeline supported by global clinical research across severe and immune-mediated conditions, Bristol-Myers aims to continue delivering breakthrough medicines for patients with unmet needs.